KLRK1 and hepatocellular carcinoma: Because we noticed a significantly greater decrease in NKG2D expression of NK cells from pre-treatment to EOT (ΔNKG2D) in patients with early-emerging HCC (Fig 4B), we conducted ROC analysis of IFN−/DAA-FU group if ΔNKG2D predicted early-emerging HCC.